Although and nothing else 32,000 n...

Although and nothing else 32,000 new cases of adenocarcinoma of the pancreas come to pass in the United States each year, it is the fourth leading cause of cancer deaths in this rural parts The overall five-year survival rate is 4 percent and localized, resectable disease has alone a 17 percent survival rate. Risk factors include smoking, certain familial cancer syndrome and familial chronic pancreatitis. The link between risk of pancreatic cancer and other factors (eg diabetes, obesity) is les clear. greatest in quantity patients present with obstructive jaundice caused by dint of compression of the bile channel in the head of the pancreas. Epigastric or back pain, vague abdominal symptoms, and weight los also are characteristic of pancreatic cancer. More than the same half of cases have distant metastasis at diagnosis. Comput tomography is the greatest in number useful diagnostic and staging tool. Ultrasonography, magnetic resonance imaging, and endoscopic retrograde cholangiopancreatography may provide additional information. The majority of tumors are not surgically resectable because of metastasis and invasion of the major canals posterior to the pancreas. Resectable tumors are treated with the Whipple course or the pylorus-preserving Whipple deed Adjuvant fluorouracil-based chemotherapy may postpone survival. For nonresectable tumors, chemotherapy with gemcitabine lengthens survival. Other agents are being studied. Radiation combined with chemotherapy has slowed progression in locally advanced cancers. from top to toe the illness and during end-of-life care, patients ne comprehensive symptom sway (Am Fam Physician 2006;73:485-92. Copyright [C] 2006 American Academy of Family Physicians.)

The American Cancer Society estimated that 31860 Americans would be diagnosed with pancreatic cancer in 2004 and that 31270 would die from the disease. (1) Pancreatic cancer accounts for solitary 2 percent of all fresh cancers in the United States, still it is the fourth leading cause of cancer deaths. At the time of diagnosis, more than individual half of pancreatic cancers have metastasized, and barely 8 percent are localized. The overall five-year survival rate is 4 percent Localized cancers have a 17 percent survival rate. Survival rates have not improved during the past 25 years. (1)

Pancreatic cancer rarely appears in persons younger than 50 years, and the risk increases with age. The incidence of pancreatic cancer is declining slowly in white men yet it is increasing in other form into groupss possibly because of changes in smoking patterns. Women account for 57 percent of of recent origin cases. (1) Smoking, (2) diabetes, (3) and obesity (4) increase risk. A link between alcohol or coffee consumption and pancreatic cancer has not been verified. (5) Physical activity; high fruit and vegetable intake (6); and, possibly, nonsteroidal anti-inflammatory remedys reduce the risk. (7) Up to 10 percent of patients report a family history of pancreatic cancer. (8) Patients with rare familial cancer syndrome or hereditary chronic pancreatitis have a substantially increased risk. (9) Research forward overexpression of specific oncogenes (10) and reduc activity of tumor suppressor gene may provide a better understanding of the pathogenesis of pancreatic cancer and lead the way to more effective screening proofs (11,12)

Clinical Presentation

Almost all pancreatic cancers are adenocarcinomas of the ductal epithelium, and symptoms primarily are caused by dint of mass effect rather than disruption of exocrine or endocrine function. The clinical features be pendent on the size and location of the tumor as well as its metastases. Jaundice, pain, and weight los are classic symptoms of pancreatic cancer. Nonspecific early symptoms ofttimes are unrecognized; therefore, most pancreatic cancers are advanced at diagnosis (Table 1) (13) More than sum of two units thirds of pancreatic cancers present itself in the head of the pancreas (Figure 1) and usually not absent as steadily increasing jaundice caused by means of biliary duct obstruction. Painless obstructive jaundice traditionally is associated with surgically resectable cancers. (14) Obstruction of the bile canal causes jaundice with disproportionately increased flushs of conjugated bilirubin and alkaline phosphatase in the progeny The urine is dark because of the high flush of conjugated bilirubin and the absence of urobilinogen. The stool is pale because of the lack of stercobilinogen in the bowel. In addition to jaundice, rising bilirubin on a levels can cause severe pruritus. As hepatic function becomes compromised, patients experience fatigue, anorexia, and bruising caused by dint of loss of clotting factors.

Patients with tumors in the visible form [i]or[/i] frame and tail of the pancreas generally not away with nonspecific pain and weight los visible form [i]or[/i] frame and tail tumors are abundant less likely to cause obstructive signs and symptoms. Patients may have pain in the epigastrium or back ranging from a brutish ache to a severe pain. The pain may be exacerbated through eating or by lying flat. Tumors in the material part and tail usually do not cause symptoms until they are large (Figure 2) and most numerous present as locally advanced disease extending to the peritoneum and spleen